Familial pseudo-Wolff-Parkinson-White syndrome

E.b. Sternick, A. Oliva, L.p. Magalhães, L.m. Gerken, K. Hong, O. Santana, Pedro Brugada, J. Brugada, R. Brugada

Research output: Contribution to journalArticlepeer-review

38 Citations (Scopus)


INTRODUCTION: PRKAG2 plays a role in regulating metabolic pathways, and mutations in this gene are associated with familial ventricular preexcitation, hypertrophic cardiomyopathy, and atrioventricular conduction disturbances. Clinico-pathologic and experimental data suggest the hypothesis of a glycogen storage disease. OBJECTIVE: To report a unique pattern of clinical features observed in individuals with a mutant PRKAG2 from two unrelated families. METHODS AND RESULTS: We studied two large families and found a total of 20 affected individuals showing a combination of sinus bradycardia, short PR interval, RBBB, intra and infrahisian conduction disturbances often requiring a pacemaker, and atrial tachyarrhythmias. Three individuals died suddenly at a young age. No patient had the Wolff-Parkinson-White (WPW) syndrome, and only two patients (10%) had myocardial hypertrophy. We performed screening of the exons and exon-intron boundaries of PRKAG2. Genetic analysis revealed a missense mutation (Arg302Gln) in the affected individuals from both families. This mutation had been described before and has been associated with the familial form of the WPW syndrome and with a high prevalence of left ventricular hypertrophy. CONCLUSION: PRKAG2 mutations are responsible for a diverse phenotype and not only the familial form of the WPW syndrome. Familial occurrence of right bundle branch block, sinus bradycardia, and short PR interval should raise suspicion of a mutant PRKAG2 gene.
Original languageEnglish
Pages (from-to)724-732
Number of pages9
JournalJ Cardiovasc Electrophysiol
Issue numberJuly
Publication statusPublished - 2006


  • ----


Dive into the research topics of 'Familial pseudo-Wolff-Parkinson-White syndrome'. Together they form a unique fingerprint.

Cite this